Lumbar Spinal Stenosis

Stryker announced a definitive agreement to acquire Vertos Medical Inc., a company that specializes in minimally invasive solutions for chronic lower back pain due to lumbar spinal stenosis, according to a press release.

According to published results, decompression with lumbar facet arthroplasty was associated with superior clinical outcomes vs. decompression with fusion for patients with spinal stenosis and spondylolisthesis.

Results showed use of decompression with fusion for patients with lumbar stenosis has increased while use of decompression alone has decreased despite previous clinical trials that demonstrated the noninferiority of decompression alone.

Premia Spine announced it has received FDA premarket approval of its Total Posterior Spine facet joint replacement system, according to a company press release.

CHICAGO — Results showed patients who underwent lumbar facet arthroplasty with a total spine system had low complication rates and significant improvements in patient-reported outcome measures at 1-year follow-up.

Aurora Spine Corporation has announced FDA clearance of a new lumbar spinal stenosis indication for use with Aurora’s ZIP platform of minimally invasive spine surgery implants, according to a press release.

Compared with transforaminal lumbar interbody fusion, the Total Posterior Spine System by Premia Spine is a more cost-effective option for treatment of degenerative lumbar spondylolisthesis and stenosis, according to results.

Published results showed use of an interspinous distractor device for lumbar spinal stenosis yielded higher cost and lower improvement in quality of life at 24 months postoperatively compared with laminectomy.